Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2003
11/11/2003US6645760 Negative strand RNA viral vector having autonomous replication capability
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645738 DNA molecules encoding the melanocortin 5 receptor protein from rhesus monkey
11/11/2003US6645734 Diagnosis of Alzheimer's disease
11/11/2003US6645730 Viable, biologically pure exfoliated fecal colonocytes isolated at normal ambient temperature
11/11/2003US6645729 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample
11/11/2003US6645727 Immunoglobulin mixture for use in the isolation of preferential stem cells
11/11/2003US6645726 Canine growth hormone secretagogue receptor
11/11/2003US6645715 Artificial cornea
11/11/2003US6645500 Method for down-regulating osteoprotegerin ligand activity
11/11/2003US6645497 Polynucleotide compositions encoding broad-spectrum δ endotoxins
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645489 Methods and devices for the long-term culture of hematopoietic progenitor cells
11/11/2003US6645488 Microencapsulated pheochromocyte of ox adrenal medulla as medicine for curing pain
11/11/2003US6645487 Method for stimulating an immune response
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2092097C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
11/06/2003WO2003091459A1 Cells for detection of influenza and parainfluenza viruses
11/06/2003WO2003091447A2 D1-1 nucleic acids, polypeptides and related methods
11/06/2003WO2003091442A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/06/2003WO2003091439A1 Reporter-selectable hepatitis c virus replicon
11/06/2003WO2003091437A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003WO2003091423A1 Adh from rhodococcus erythropolis
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003WO2003091412A2 Generation of plants with improved pathogen resistance
11/06/2003WO2003091405A2 In vitro ischemia model
11/06/2003WO2003091401A2 Multi plasmid system for the production of influenza virus
11/06/2003WO2003091399A2 Production and use of salt tolerant and culture density tolerant organisms
11/06/2003WO2003091396A2 Polypeptides and biosynthetic pathways
11/06/2003WO2003091380A2 Method for preparing tissue constructs
11/06/2003WO2003091280A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003090689A2 Neurodegenerative disorder treatment using gdnf secreting neural cells
11/06/2003WO2003090526A1 Production of cloned offspring from cooled carcasses
11/06/2003WO2003090515A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003090513A2 Bi-specific antigen-binding compositions and related methods
11/06/2003WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/06/2003WO2003081249A3 Method for the detection of prion proteins
11/06/2003WO2003078607A3 Tissue specific signal-plexes to dedifferentiate and redifferentiate cells
11/06/2003WO2003070171A3 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
11/06/2003WO2003068931A3 Purification of the leading front migratory cells
11/06/2003WO2003063575A3 Endothelialization of vascular surfaces
11/06/2003WO2003055983A3 Targeted retrograde gene delivery to motor neurons
11/06/2003WO2003054153A3 Apyrase polypeptides and nucleic acids encoding same
11/06/2003WO2003043486A3 Matrix for the production of tissue engineered ligaments, tendons and other tissue
11/06/2003WO2003035004A3 Immunotherapy for reversing immune suppression
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003029402A3 Unique properties of stem cells
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003027242A3 Fas ligand
11/06/2003WO2003025167A3 Cultured stromal cells and uses thereof
11/06/2003WO2003024393A3 Autologous t-cell vaccines materials and method
11/06/2003WO2003023021A3 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
11/06/2003WO2003016354A3 Recombinant anti-plasmodium falciparum antibodies
11/06/2003WO2003015714A3 Compositions and therapeutic methods for viral infection
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003006602A3 Subtilase variants
11/06/2003WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2002098916A3 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
11/06/2003WO2002096939A3 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
11/06/2003WO2002094313A3 Vaccine composition
11/06/2003WO2002092773A3 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/06/2003WO2002090523A3 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002079258A3 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
11/06/2003WO2002077200A3 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002064728A3 Incubator and incubation method monitoring the organism to be incubated
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002061115A3 Method for the evolutionary design of biochemical reaction networks
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002059266A3 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor
11/06/2003WO2002057469A8 Modulating developmental transitions in plants
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002051980A3 In vitro-derived adult pluripotent stem cells and uses therefor
11/06/2003WO2002050242A3 Tissue growth method and apparatus
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002046379A3 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002044199A3 Neurotoxins with enhanced target specificity
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002009639A3 Methods and pharmaceutical compositions for healing wounds
11/06/2003WO2001095701A8 Methods for somatic embryo formation and plant regeneration of beta vulgaris
11/06/2003WO2001078503A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/06/2003US20030208795 Methods for the production of transgenic plants using apical shoot tip
11/06/2003US20030208789 Producing plants in which expression of an insecticidal protein is regulated by the wound- inducible orphan receptor (TR2) promoter
11/06/2003US20030208784 Producing or selecting cells or transgenic animals containing inhibited genes for the analysis of gene function
11/06/2003US20030208783 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
11/06/2003US20030208781 By immunization with any desired antigen
1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 1827